208 related articles for article (PubMed ID: 25214750)
21. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Ameli N; Schatzberg AF; Murphy GM
Nicotine Tob Res; 2015 Sep; 17(9):1126-33. PubMed ID: 25572450
[TBL] [Abstract][Full Text] [Related]
22. Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan.
Al-Eitan L; Shatnawi M; Alghamdi M
BMC Psychiatry; 2024 Jun; 24(1):436. PubMed ID: 38862938
[TBL] [Abstract][Full Text] [Related]
23. Effect of the rs1051730-rs16969968 variant and smoking cessation treatment: a meta-analysis.
Leung T; Bergen A; Munafò MR; De Ruyck K; Selby P; De Luca V
Pharmacogenomics; 2015; 16(7):713-20. PubMed ID: 25950378
[TBL] [Abstract][Full Text] [Related]
24. The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics.
Lassi G; Taylor AE; Timpson NJ; Kenny PJ; Mather RJ; Eisen T; Munafò MR
Trends Neurosci; 2016 Dec; 39(12):851-861. PubMed ID: 27871728
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain.
Ohi K; Kuwata A; Shimada T; Kataoka Y; Yasuyama T; Uehara T; Kawasaki Y
Schizophr Bull; 2019 Jun; 45(4):813-823. PubMed ID: 30202994
[TBL] [Abstract][Full Text] [Related]
26. Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966.
Kaakinen M; Ducci F; Sillanpää MJ; Läärä E; Järvelin MR
PLoS One; 2012; 7(9):e46557. PubMed ID: 23029550
[TBL] [Abstract][Full Text] [Related]
27. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.
Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ
Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic receptor gene variants influence susceptibility to heavy smoking.
Stevens VL; Bierut LJ; Talbot JT; Wang JC; Sun J; Hinrichs AL; Thun MJ; Goate A; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3517-25. PubMed ID: 19029397
[TBL] [Abstract][Full Text] [Related]
29. An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.
Gao J; Xu H; Weinberg C; Huang X; Park Y; Hollenbeck A; Blair A; Schatzkin A; Burch L; Chen H
Neurodegener Dis; 2011; 8(5):296-9. PubMed ID: 21228559
[TBL] [Abstract][Full Text] [Related]
30. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
Wen L; Jiang K; Yuan W; Cui W; Li MD
Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
[TBL] [Abstract][Full Text] [Related]
31. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
Chen LS; Hung RJ; Baker T; Horton A; Culverhouse R; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Lutz S; Rosenberger A; Aben KK; Andrew AS; Breslau N; Chang SC; Dieffenbach AK; Dienemann H; Frederiksen B; Han J; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden HF; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Heinrich J; Hokanson JE; Hunter DJ; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare D; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Kraft P; Amos CI; Bierut LJ
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25873736
[TBL] [Abstract][Full Text] [Related]
32. TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood.
Ducci F; Kaakinen M; Pouta A; Hartikainen AL; Veijola J; Isohanni M; Charoen P; Coin L; Hoggart C; Ekelund J; Peltonen L; Freimer N; Elliott P; Schumann G; Järvelin MR
Biol Psychiatry; 2011 Apr; 69(7):650-60. PubMed ID: 21168125
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index.
Freathy RM; Kazeem GR; Morris RW; Johnson PC; Paternoster L; Ebrahim S; Hattersley AT; Hill A; Hingorani AD; Holst C; Jefferis BJ; Kring SI; Mooser V; Padmanabhan S; Preisig M; Ring SM; Sattar N; Upton MN; Vollenweider P; Waeber G; Sørensen TI; Frayling TM; Watt G; Lawlor DA; Whincup PH; Tozzi F; Davey Smith G; Munafò M
Int J Epidemiol; 2011 Dec; 40(6):1617-28. PubMed ID: 21593077
[TBL] [Abstract][Full Text] [Related]
34. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.
Bousman CA; Rivard C; Haese JD; Ambrosone C; Hyland A
Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):227-35. PubMed ID: 22223462
[TBL] [Abstract][Full Text] [Related]
35. Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study.
Hällfors J; Loukola A; Pitkäniemi J; Broms U; Männistö S; Salomaa V; Heliövaara M; Lehtimäki T; Raitakari O; Madden PA; Heath AC; Montgomery GW; Martin NG; Korhonen T; Kaprio J
Int J Mol Epidemiol Genet; 2013; 4(2):109-19. PubMed ID: 23875064
[TBL] [Abstract][Full Text] [Related]
36. CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.
Chen LS; Bach RG; Lenzini PA; Spertus JA; Bierut LJ; Cresci S
Nicotine Tob Res; 2014 Sep; 16(9):1224-31. PubMed ID: 24727484
[TBL] [Abstract][Full Text] [Related]
37. A CHRNA5 Smoking Risk Variant Decreases the Aversive Effects of Nicotine in Humans.
Jensen KP; DeVito EE; Herman AI; Valentine GW; Gelernter J; Sofuoglu M
Neuropsychopharmacology; 2015 Nov; 40(12):2813-21. PubMed ID: 25948103
[TBL] [Abstract][Full Text] [Related]
38. Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster.
Stephens SH; Hoft NR; Schlaepfer IR; Young SE; Corley RC; McQueen MB; Hopfer C; Crowley T; Stallings M; Hewitt J; Ehringer MA
Behav Genet; 2012 May; 42(3):402-14. PubMed ID: 22042234
[TBL] [Abstract][Full Text] [Related]
39. Variants in nicotinic receptors and risk for nicotine dependence.
Bierut LJ; Stitzel JA; Wang JC; Hinrichs AL; Grucza RA; Xuei X; Saccone NL; Saccone SF; Bertelsen S; Fox L; Horton WJ; Breslau N; Budde J; Cloninger CR; Dick DM; Foroud T; Hatsukami D; Hesselbrock V; Johnson EO; Kramer J; Kuperman S; Madden PA; Mayo K; Nurnberger J; Pomerleau O; Porjesz B; Reyes O; Schuckit M; Swan G; Tischfield JA; Edenberg HJ; Rice JP; Goate AM
Am J Psychiatry; 2008 Sep; 165(9):1163-71. PubMed ID: 18519524
[TBL] [Abstract][Full Text] [Related]
40. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Falcone M; Jepson C; Benowitz N; Bergen AW; Pinto A; Wileyto EP; Baldwin D; Tyndale RF; Lerman C; Ray R
Nicotine Tob Res; 2011 Jun; 13(6):498-503. PubMed ID: 21385908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
